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Abstract
Background: Approximately 20% of patients report persistent and disabling pain following total knee arthroplasty
(TKA) despite an apparently normally functioning prosthesis. One potential risk factor for unexplained persistent
pain is high levels of pain catastrophizing. We designed a three-arm trial to determine if a pain coping skills training
program, delivered prior to TKA, effectively reduces function-limiting pain following the procedure in patients with
high levels of pain catastrophizing.
Methods/design: The trial will be conducted at four University-based sites in the US. A sample of 402 patients with
high levels of pain catastrophizing will be randomly assigned to either a pain coping skills training arm, an arthritis
education control arm or usual care. Pain coping skills will be delivered by physical therapists trained and
supervised by clinical psychologist experts. Arthritis education will be delivered by nurses trained in the delivery of
arthritis-related content. The primary outcome will be change in Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC) Pain scale score 12 months following surgery. A variety of secondary clinical and
economic outcomes also will be evaluated.
Discussion: The trial will be conducted at four University-based sites in the US. A sample of 402 patients with high
levels of pain catastrophizing will be randomly assigned to either a pain coping skills training arm, an arthritis
education control arm or usual care. Pain coping skills will be delivered by physical therapists trained and
supervised by clinical psychologist experts. Arthritis education will be delivered by nurses trained in the delivery of
arthritis-related content. The primary outcome will be change in Western Ontario and McMaster Universities
Osteoarthritis Index (WOMAC) Pain scale score 12 months following surgery. A variety of secondary clinical and
economic outcomes also will be evaluated.
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Background
Pain is the predominant complaint of patients seeking
total knee arthroplasty (TKA) [1-3], a common and gen-
erally effective procedure for patients with advanced
knee arthritis [1]. Kurtz and colleagues estimated that in
2010, surgeons would perform over 700,000 TKA proce-
dures in the US and projections suggest 3.5 million
TKAs annually by 2030 [4]. Cost data for TKAs also are
impressive. Mean procedural and rehabilitation costs per
patient, reported in 2006 dollars, were approximately
$20,700 per primary surgery and $24,500 per revision
surgery [5] plus significant patient costs incurred over
12 months following surgery [6].
Serious early surgical complications such as pulmonary
embolism or joint infection lead to poor outcomes.
However, the incidence of these adverse events is very
low - approximately 2% of all surgeries. Failure of the
prosthesis is typically a late complication occurring years
following the surgery and accounts for approximately 5%
of poor outcomes [7]. The large majority of “poor” out-
comes following knee arthroplasty are attributed to disab-
ling pain and impaired function that is not related to early
complications or prosthetic loosening. In large patient
samples, improvements in pain or function scores have
consistently been on the order of 40% to 60% relative to
baseline, from 6 months to 2 years postoperatively [8-16].
However, some patients respond poorly to the surgery.
For example, Puolakka and colleagues found that 36% of
433 patients reported daily disturbing pain four months
or more after surgery [17,18]. Hawker et al. reported
similar estimates 2 to 7 years following arthroplasty [19].
Only a third of patients report no functional problems
following surgery [20] and approximately 20% report
dissatisfaction with their functional ability a year or
more after surgery [21]. Functional deficits following
surgery are observed in a wide range of activities, with
up to 40% of patients still requiring the use of an assist-
ive device to ambulate [19]. Most recently, Beswick and
colleagues reported in a systematic review that 20% of
patients in high quality cohort studies reported persist-
ent function-limiting pain six months or more following
TKA [22].
Disabling pain and reduced function is a large and as
yet unsolved problem that has a dramatic impact on
quality of life and productivity. For example, revision
surgery rates are influenced by persistent pain and
impaired function. Roberts and colleagues conducted a
survival analysis of 4,400 patients with knee arthroplasty
and found that 15 years following surgery, a total of 239
knees required revision and up to 35% were for unex-
plained pain. Extrapolating to current estimates, as many
as 35% of 55,000 revision arthroplasty surgeries in the
US in 2010 may be attributable to unexplained persistent
pain and subsequent poor function [23].
A barrier to improving postoperative outcomes is that
traditionally, knee arthroplasty has been presumed to be
a highly effective procedure. TKA perioperative proto-
cols have historically not incorporated routine screening
for patients at-risk for post-surgery persistent pain or
compromised function because this area has not been
scientifically investigated. This culture has strong poten-
tial for change, however, because recent research has
begun to acknowledge that unexplained poor outcomes
occur [22]. Predictors of these poor outcomes following
knee arthroplasty have been identified [24-27]. Among
the most consistent and powerful psychological predic-
tors of poor outcome following knee arthroplasty is pain
catastrophizing [17,26,28-32]. Individuals who catastro-
phize tend to ruminate about pain, magnify the threat
value of pain and feel helpless when dealing with pain
[33,34].
Additional impetus to address the issue of persistent
pain was proposed by the National Institutes of Health
(NIH). An NIH consensus panel was convened to review
existing evidence regarding the use of knee arthroplasty
surgery and to make recommendations for future re-
search to improve the care for these patients [1]. The
panel placed high priority on research examining the im-
pact of perioperative interventions for these patients.
Our trial will specifically target this research need. If a
high-quality trial demonstrates that pain coping skills
training is successful at improving outcomes for at-risk
patients with poor pain coping, and is cost effective,
current clinical practice paradigms could be significantly
improved.
The primary aim of our study is to assess the efficacy
of a physical therapist-delivered pain coping skills train-
ing program in reducing knee pain and improving func-
tion. Our two primary hypotheses are that in patients
scheduled for knee arthroplasty and with comorbid pain
catastrophizing: (1) Pain coping skills training is more ef-
fective than arthritis education in decreasing knee pain
during functional activities, and (2) Pain coping skills
training is more effective than usual care in decreasing
knee pain during functional activities. We also will exam-
ine two sets of secondary hypotheses: (1) Pain coping
skills training is more effective than arthritis education
or usual care in improving self-reported function, phys-
ical performance, pain intensity, pain catastrophizing,
and patient global ratings of improvement and (2) Pain
coping skills training will reduce direct medical costs and
indirect (i.e. patient time) costs relative to arthritis edu-
cation and usual care. We hypothesize that, in addition
to accounting for costs associated with pain coping skills
training, the intervention will be cost saving or cost-
effective relative to arthritis care education and usual
care as measured by the incremental cost per quality-
adjusted life-year. We will also determine if treatment
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benefits are mediated by changes in pain catastrophizing:
We hypothesize that treatment-related changes in pain
catastrophizing will mediate treatment-related improve-
ments in pain and self-reported function during recovery.
Method/design
Study design
The KASTPain Trial is a three-arm randomized trial
(see Figure 1) funded by the National Institute of Arth-
ritis, Musculoskeletal and Skin Diseases/National Insti-
tutes of Health (1UM1AR062800). The investigators,
research assistants assessing outcomes, and patients
assigned to two of the three study arms will be blinded to
group assignment. Potential subjects will be informed that
they will be randomly assigned to one of two different
educational treatments or usual care. They will likely not
know whether they will be receiving the treatment with
the hypothesized key ingredient (pain coping skills train-
ing). The protocol conforms to the CONSORT guidelines
for nonpharmacologic interventions [35]. Human subjects
approval for the study has been obtained from the
Virginia Commonwealth University Institutional Review
Board (HM14326).
Study population
We will recruit 402 patients who consult with participat-
ing orthopaedic surgeons in one of four sites for TKA.
These sites are: (1) Virginia Commonwealth University
in Richmond, Virginia; (2) Southern Illinois University in
Springfield, Illinois; (3) Duke University in Durham,
North Carolina; and (4) Wake Forest University, Winston-
Salem North Carolina. To be eligible for participation all
patients must: (1) be able to read and speak English and
provide informed consent; (2) be 45 years or older; (3) have
a diagnosis of osteoarthritis as determined by the patients’
orthopaedic surgeons; (4) be scheduled for an elective
unilateral total knee arthroplasty no sooner than 2 weeks
or later than 8 weeks from the time of recruitment; and
Patient Screening
Baseline Assessment
Randomization
 by surgeon
Decline
Fail inclusion criteria
Meet exclusion criteria
Usual Care
Arthritis Education
Control delivered by
nurses
Pain Coping Skills
Training delivered by
physical therapists
1 week pre-operative assessment
1 year post-operative assessment
6 month post-operative assessment
1 week post-operative assessment
2 month post-operative assessment
End of study
Figure 1 Legend: The figure illustrates the flow of subjects through the trial.
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(5) score of ≥ 16 on the Pain Catastrophizing Scale and ≥5
on the WOMAC Pain scale. Scores of 16 or greater on the
Pain Catastrophizing Scale suggest at least a moderately se-
vere pain catastrophizing while scores of ≥ 5 on the
WOMAC Pain Scale suggests greater than minor function
limiting pain. Patients will be excluded if they: (1) are
scheduled for revision arthroplasty surgery; (2) are unable
to or decline consent for study participation; (3) have a
self-reported diagnosis of inflammatory arthritis (i.e.
rheumatoid arthritis, psoriatic arthritis, systemic lupus
erythematosis, ankylosing spondylitis); (4) have TKA
scheduled because of a fracture, malignancy or an infec-
tion; (5) are scheduled for bilateral TKA; (6) are scheduled
for unicompartmental arthroplasty; (7) report plans to
undergo hip or knee arthroplasty within one year after
current TKA; (8) underwent contralateral knee arthro-
plasty surgery or hip arthroplasty surgery within 1 year of
currently planned surgery; or (9) score 20 or higher on the
Patient Health Questionnaire-8 (PHQ-8) depression
screener which indicates likely severe depression [36,37].
Pregnancy is an “automatic” exclusion because women
who are pregnant are excluded by their physicians from
TKA.
Procedures
All patients scheduled for TKA with orthopaedic surgeons
who conduct at least 50 TKAs per year at one of the four
university-based study sites will potentially be eligible for
study. We will only recruit surgeons who conduct≥ 50
TKAs per year because of the potential influence of TKA
volume on outcome [38]. Following an opt-out period,
each patient will be contacted by phone to assess for eligi-
bility after providing verbal consent for screening. All
patients enrolled in the study will attend an in-person ses-
sion to read and sign the consent form and complete pre-
operative data collection procedures. In addition, all
patients will complete a series of performance-based mea-
sures which include a 6-minute walk test [39] and the short
physical performance battery [40], which includes a series
of tests of walking speed, balance and strength.
Two in-person data collection sessions will occur for
each patient, one at the baseline visit and the other at 1
year following TKA. In addition, staff that are blinded to
group assignment will contact patients by phone at 4
different time points; 1 week prior to and 1 week fol-
lowing TKA, 2 months, 6 months following TKA (see
Figure 1) to collect outcome data. Key measures
obtained at each time point will be the Pain Catastro-
phizing Scale, the WOMAC Scale, and a knee pain
rating scale [42].
Randomization and allocation concealment
All eligible subjects will be randomized following base-
line data collection into the pain coping skills arm, the
arthritis education control arm or the usual care arm.
Patients will be blinded to study hypotheses and will be
informed that the study is examining the potential bene-
fits of two approaches to improve outcomes as com-
pared to usual care. The study statistician will prepare a
random numbers table to permit randomization in per-
muted block sizes of 3 and 6, stratified by surgeon. To
conceal randomization, assignment will occur via the
web interface only after all baseline data are collected.
The physical therapists delivering the pain coping skills
and the nurses delivering the arthritis education cannot
be blinded.
Interventions
Participants randomized to one of the two treatment
arms will receive eight 1-hour sessions of one-on-one in-
struction to be delivered over a 2-month period begin-
ning approximately 2 weeks prior to surgery and ending
6 weeks following surgery. The first session will be deliv-
ered in-person and subsequent sessions will be delivered
via the telephone. Telephone-based behavioral interven-
tions for pain management have been shown to be effective
[42,43].
Pain coping skills
The 8-session pain coping skills training (CST) will be
delivered over a 2-month period by physical therapists.
This number of sessions of CST has been shown to be
effective in several behavioral trials [44-50]. Study phys-
ical therapists must have practiced for at least 2 years
and reported experience in the treatment of patients
with TKA.
The (CST) protocol will: (1) provide a rationale for the
coping skills intervention; (2) train patients in cognitive
restructuring as well as a variety of skills that provide
patients with opportunities to observe the impact of
coping skills on changes in negative pain-related cogni-
tions typical of pain catastrophizing (i.e. thoughts related
to pain rumination, pain magnification, and helplessness
in the face of pain); and (3) provide training in strategies
for enhancing maintenance of gain following treatment.
Melzack and Wall's gate control model of pain will be
used to help patients reconceptualize their pain and
emphasize their own abilities to control pain. The gate
control model highlights the role that thoughts, feelings,
and behaviors can play in influencing the transmission
of noxious signals from the periphery to the brain [51].
Training in pain coping skills will be described as a way
of changing thoughts, feelings, and behaviors that con-
tribute to pain.
Using techniques drawn from cognitive therapy,
patients will be taught how to identify irrational, mal-
adaptive, and catastrophic pain-related thoughts and to
replace these with alternative, rational, reassuring and
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adaptive thoughts [52]. Self-instructional training will be
used to teach patients how to use calming self-
statements as a way of coping with pain flares [53].
Activity-rest cycling and pleasant activity scheduling
[54-56] will be used to help patients increase their activ-
ity level and observe the resultant impact on their pain-
related cognitions. Activity-rest cycling teaches patients
to target activities they tend to overdo (e.g. prolonged
standing or walking while shopping) and learn to break
these activities into periods of moderate activity (e.g. 30
minutes of shopping) followed by a limited rest break
(e.g. 5 minutes of rest). Over time, the goal is to help
patients raise their activity level by increasing the length
of their activity and decreasing the length of their rest
periods. In pleasant activity scheduling, patients learn
how to identify activities they enjoy doing (e.g. reading,
doing hobbies, and visiting friends) or that give them a
sense of mastery (learning how to do something new
such as typing or a new language) and then set and
record weekly activity goals.
Patients also will be trained in three attention diver-
sion methods that can be used to alter negative pain
related cognitions: relaxation, imagery, and distraction.
Progressive relaxation training [57] will help patients
learn to concentrate on muscle tension signals and use
them as cues to relax. Patients will be taught how to use
pleasant imagery as a way to alter their pain-related
thought patterns and foster relaxation [58]. Distraction
training will involve training in how to focus on physical
stimuli (e.g. a photograph or picture of a nature scene)
or auditory stimuli (e.g. listening to music) when experi-
encing increased pain [58]. Using relapse prevention
methods, each patient will develop a written mainten-
ance plan that includes the list of pain coping skills
learned during the study, potential high risk situations,
early warning signs of setbacks, and plans about how the
patient might apply these skills in dealing with future
setbacks and challenges. Table 1 highlights the key
elements of the CST protocol.
Arthritis education
Patients randomly assigned to the arthritis education
arm will receive detailed information from a registered
or licensed practical nurse educator about osteoarthritis
and its treatment. The arthritis education intervention
will control for participation in a trial, time and clinician
attention. The arthritis education sessions will use a
presentation and discussion format similar to that ori-
ginally described by Lorig for arthritis education [59-62].
Figures and discussion sessions will present information
on the nature of arthritis, the post-operative course of
knee arthroplasty, treatment of osteoarthritis, the role of
exercise, joint protection and making future treatment
decisions.
This general approach to an arthritis education com-
parison condition has been used successfully in many
behavioral studies and in several trials conducted by
Keefe and Jensen [44-50,62]. An education comparison
condition is a credible treatment and allows us to test
whether the "pain coping" component of the experimen-
tal intervention is the specific treatment element that
reduces pain and improves function over that seen in
patients who receive a similar dose of time and attention
from a health professional, but no training in pain cop-
ing skills.
Usual care
We have added a “usual care” group to determine real
world effects of pain coping skills. Patients in the usual
care group will only receive care that they would have
routinely received had they not been entered in the
study. All patients in this group will undergo the same
data collection procedures as patients in the other two
treatment arms with the exception of the eight treat-
ment sessions.
Co-interventions
Patients are routinely prescribed medications for pain
control and are referred for physical therapy following
TKA. Data regarding medication and extent of rehabili-
tation therapies will be tracked throughout the study
period and will be adjusted for, if necessary, in the
analyses.
Treatment adherence and fidelity
Because multiple study sites will participate and increase
the risk of low fidelity due to differing approaches in ap-
plying the interventions, the research team will take a
number of steps to ensure that the treatment protocols
for CST as well as arthritis education are delivered uni-
formly by all treatment providers involved in the study.
First, all pain coping skills training will be delivered by
physical therapists with at least 2 years of clinical experi-
ence including the treatment of patients following TKA.
Second, all physical therapists will receive coping skills
training in a 2-day workshop delivered by clinical psych-
ologist experts at Duke University. Experienced nurse
Table 1 Components of the pain coping skills
intervention
Training objective Coping skill training methods
Altering Cognitions to Change
Pain Catastrophizing
Cognitive Restructuring,
Self-Instructional Training
Altering Activity Patterns To
Change Pain Catastrophizing
Activity-Rest Cycling, Goal Setting
Using Attention Diversion to
Change Pain Catastrophizing
Relaxation Training,
Imagery, Distraction
Enhancing Maintenance Relapse Prevention Training
Riddle et al. BMC Musculoskeletal Disorders 2012, 13:149 Page 5 of 11
http://www.biomedcentral.com/1471-2474/13/149
educators will all be trained in 2-day workshops by
DLR, a physical therapist with 30 years of experience
and research in arthritis and rehabilitation, to provide
the arthritis education. Third, all physical therapists and
nurse educators will be provided with detailed treat-
ment manuals and the treatment strategies will be
taught through didactic instruction, illustrations of
techniques from model cases, and role-play of common
scenarios. Fourth, we will institute several “best prac-
tices” to enhance and monitor treatment fidelity of the
pain coping skills training and arthritis education which
include: (1) careful attention to the study design; (2) in-
tensive training; (3) role playing of treatment skills en-
actment during training; and (4) on-line documentation
of treatment delivery. All sessions for both groups will
be audiotaped and supervisors or investigators will re-
view tapes periodically for each physical therapist and
nurse educator during the study. Remedial training will
be provided for those clinicians who deviate from
established protocol.
Outcomes
The primary outcome measure and endpoint will be the
WOMAC Pain score measured 1 year following knee
arthroplasty [63-67]. The WOMAC has been studied ex-
tensively and its scales have been shown to be reliable and
valid for quantifying the extent of both pain and disability
in patients undergoing knee arthroplasty [16,68,69]. Sec-
ondary outcome measures will be the WOMAC Disability
scale, Pain Catastrophizing Scale (PCS) [33,70,71], a verbal
pain rating scale [72,73], and a patient global rating of
change scale measured on a numerical rating scale from
-5 (vastly worse) to +5 (completely recovered) [74-76]. All
outcome measures are summarized in Table 2. Outcomes
will be measured pre-operatively, 2 months, 6 months and
1 year post-surgery. To assess for potential mediating
effects of pain catastrophizing on outcomes, the PCS and
WOMAC scales will be administered one week prior to
and 1 week following TKA. Two performance-based mea-
sures, the 6-minute walk test [39,77] and the Short Phys-
ical Performance Battery will be assessed at baseline and 1
year post-surgery [40].
Power considerations and data analysis
The primary endpoint will be the WOMAC Pain score
at 1 year. Changes of 2 or more points in the 20-point
WOMAC Pain scale indicate clinically important differ-
ences in pain-related function between individual
patients [78-81]. We powered the KASTPain study to
detect a difference of at least 2 points between the mean
pain scores in the pain coping skills group and the arth-
ritis education group [82].
Using a two-sided, two-group t-test of differences in
means with alpha set at 0.05 and assuming the
intervention difference minus the arthritis education
control difference is at least 2 WOMAC Pain points, a
sample size of 107 in each group will provide 91% power
to detect this difference, assuming that the common
standard deviation is 4.34 (based on pilot work). This
corresponds to a moderate effect size of 0.46 which is
consistent with the effect of other behavioral interven-
tions for knee arthritis [83-85]. This sample size also pro-
vides 80% power to detect a 20% difference between
groups in the proportion of patients with a 50% or
greater improvements in WOMAC pain relative to base-
line scores [9,10,12-15,86]. This effect is equivalent to an
odds ratio of 2.25 and a number needed to treat (NNT)
of 5 [87].
The required sample size is 321 (107 patients per arm)
for the planned three-arm trial. Based on our pilot study,
we expect 5% attrition due to early drop-out resulting
from cancelled surgery. Patients who undergo surgery
and drop out due to lack of interest, unrelated medical
illness or loss of follow-up will be included in the intent-
to-treat analysis. Our previous work with similar types of
patients suggests that loss to follow-up will likely be ap-
proximately 20% one year following surgery [14,30].
Therefore, 402 patients (134 patients per study arm) will
need to be enrolled in the trial. The accrual and retention
numbers will be monitored during the study to assure
that sample size estimates are reached. Stratification by
surgeon is expected to reduce outcome variability and
thereby increase power.
Table 2 Summary of primary and secondary outcome and
cost measure
Measure Specific instrument
Primary outcome Measure
Function related pain WOMAC Pain Scale
(3.1 Likert version)
Secondary Outcome Measures
Self-reported function WOMAC Physical Function
Scale (3.1 Likert version)
Pain catastrophizing Pain Catastrophizing Scale
Pain intensity Numeric Pain Rating Scale
Global rating Global rating of change scale
Walk test 6-minute walk test
Physical Performance Short Physical
Performance Battery
Cost Measures
Employment status Self-report
Healthcare visits Self-report
Emergency room or
urgent care visits
Self-report
Inpatient admissions Self-report
Health Status EQ-5D-5L
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Intention to treat (ITT) will be the primary approach
for all analyses. Because we expect that some patients
will provide consent for our study but may opt out of
surgery for a variety of reasons, we will compare the
ITT analysis to the results for patients who actually
undergo surgery (i.e., attrition analysis). For the primary
analysis, the effect of treatment will be assessed using
linear mixed models with time as a repeated factor. The
model will account for correlation over time within par-
ticipants, correlations within surgeons, and baseline cov-
ariates. Surgical approach, complications, medication
and physical therapy use will be assessed for potential
effects. Restricted maximum likelihood method (REML),
which uses all available data, will be used to estimate the
linear mixed model. REML is the default option in mul-
tiple software packages for mixed models including SAS
and Mplus. Wothke has shown that no other missing
data handling method, regardless of missing data mech-
anism, performs better [88].
Estimates of the effect of pain coping skills training will
be obtained by constructing linear contrasts to compare
the outcome at each of the key time points (baseline, 2
months, 6 months and 1 year) between the pain coping
skills group and the two control groups, with adjustment
for the other variables. Analyses of the secondary outcome
variables will be conducted using a similar approach. For
the analyses using dichotomous outcomes of ≥50% im-
provement at 6 months and 12 months, generalized linear
models with logistic regression will be used to compare
the proportion of patients with ≥50% improvement after
adjustment for covariates.
As an additional secondary analysis, we also will exam-
ine the effects of potential moderators. Moderators are
patient characteristics that predict treatment effects [89].
Additional psychosocial issues may influence treatment
effects in knee arthroplasty. Potential moderators for
patients with knee arthroplasty who may particularly
benefit from pain coping skills training are the following:
treatment expectations prior to surgery [90-92], self effi-
cacy [93,94], extent of social support [9,95] and depres-
sion [28]. Because our study is not powered to test for
these potential moderators, they will be assessed in the
context of hypothesis generation rather than hypothesis
testing and only for the primary outcome of WOMAC
Pain at 1 year. This analysis will be performed by includ-
ing a two-way Moderator X Treatment group interaction
term in the mixed models analyses. We will assess
whether these variables independently predict those
patients who are more likely to respond to pain coping
skills training versus arthritis education or usual care.
Pain coping skills training emphasizes pain coping strat-
egies, unlike usual care or arthritis education and be-
cause of this emphasis, we suspect that coping strategies
training will be particularly effective in patients with
adverse psychosocial characteristics. Knowing whether
any of these potential moderators actually predict re-
sponse to treatment may aid in better identifying indivi-
duals who are more likely to respond to the intervention.
Economic evaluation
Medical resource use and total costs
We will also compare medical resource use and mean
total costs incurred over the one-year follow-up period
in the KASTPain study between patients randomized to
coping skills training vs. arthritis education vs. usual
care. Counts of medical resource use will include in-
patient stays, outpatient visits to physicians, physical
therapists and other providers, and days of pain medica-
tion. Sources for unit costs assigned to medical resource
use will include average Medicare payments for inpatient
care and outpatient services and average wholesale
prices published in the Red Book for medications. The
TEAM-HF Costing Tool will be used to estimate inter-
vention costs by accounting for providers’ time spent
delivering the study intervention [96]. Total costs will
consist of direct medical costs associated with the study
interventions and costs associated with TKA, rehabilita-
tion, complications and pain management as well as
patients’ time costs associated with receipt of the study
interventions. Total costs, from the societal perspective,
will consist of direct medical costs, intervention-related
costs and indirect costs. From the health care system (or
payer) perspective, indirect costs will be excluded. Sensi-
tivity analyses will be performed to evaluate the impact
of scaling up the intervention (i.e. more patients per ses-
sion; fixed costs allocated over more patients) and meth-
odological choices for cost assignment [97,98].
Cost-Effectiveness analysis
A cost-effectiveness analysis will also be performed. In-
cremental cost-effectiveness ratios (ICER) will be calcu-
lated as the difference in the mean costs per patient
between study arms divided by the difference in esti-
mated quality-adjusted life-years (QALYS). Mean costs
will be estimated as described above. QALYs will be
estimated using patient-level utility estimates derived
from the EQ-5D, administered at baseline, 2 months, 6
months and 1 year [99]. Because the study interventions
represent fixed-, one-time costs while the benefits of the
interventions may last beyond the one year follow-up
period in the KASTPain study, we will conduct sensitiv-
ity analyses that extrapolate differences in utilities mea-
sured at the end of follow-up over 3, 5, and 10 years,
assuming that the interventions do not differentially im-
pact survival. If we observe statistically significant differ-
ences in costs (not including costs for the intervention
or initial surgery) between treatment arms at 12 months,
we will extrapolate treatment-specific cost estimates over
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3, 5, and 10 years, consistent with the time period for
QALYs. We will evaluate uncertainty by estimating 95%
CIs for estimates of costs, QALYs and measures of cost-
effectiveness (i.e. ICERs or net health benefits [100])
using nonparametric bootstrapping.
Discussion
Our study will be the first to examine the efficacy of a
pain coping skills training intervention delivered by
physical therapists to patients at risk for poor outcome
following orthopaedic surgery. The use of physical
therapists as interventionists is innovative because the
intervention is traditionally delivered by clinical psy-
chologists. However, given the limited availability of
clinical psychologists and the large volume of TKA
procedures, physical therapists routinely treat patients
prior to and following TKA and are optimally posi-
tioned to provide coping skills training.
Previous work by our group [30] and others
[28,29,32,101] has identified a TKA patient subgroup at
risk for poor outcome. Patients with high levels of pain
catastrophizing have been consistently shown to have a
higher rate of persistent pain and compromised function
compared to non-catastrophizers [28,102,103]. Current
clinical paradigms do not discuss formal identification of
patients at-risk for poor outcome due to ineffective pain
coping [104,105] nor do these paradigms address the use
of perioperative interventions to reduce poor outcome
risk. Our trial will provide high-quality evidence to poten-
tially challenge this practice paradigm. If the KASTPain
intervention is effective, the research will provide strong
evidence to consider augmenting this traditional approach
with a scalable intervention that could improve pain and
functioning for thousands of patients with TKA who are
at high risk for poor outcomes.
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